Login / Signup

Implantable loop recorders in patients with Brugada syndrome: the BruLoop study.

Marco BergontiFrederic SacherElena ArbeloLia CrottiAvi SabbagMichela CasellaJohan SaenenAndrea RossiCinzia MonacoLuigi PannonePaolo CompagnucciVincenzo RussoEyal HellerAmato SantoroPaola BerneAntonio BisignaniEnrico BaldiOlivier Van LeuvenFederico MiglioreLorenzo MarconFederica DagradiIrene SfondriniFederico LandraAngelo ComuneMaría Cespón-FernándezMartina NestiFrancesco SantoroMichele MagnocavalloAlessandro VicentiniSergio ContiValentina RibattiPedro BrugadaCarlo de AsmundisJosep BrugadaClaudio TondoPeter J SchwartzMichel HaissaguerreAngelo AuricchioGiulio Conte
Published in: European heart journal (2024)
ILR detects arrhythmic events in nearly 30% of symptomatic BrS patients, leading to appropriate therapy in 70% of them. The most commonly detected arrhythmias are AAs and BAs, while VAs are detected only in 7% of cases. Symptom status can be used to guide ILR implantation.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • prognostic factors
  • peritoneal dialysis
  • stem cells
  • patient reported
  • case report
  • patient reported outcomes